US big company (Cephalon) takeover bid last year at $4.8 prove the credibility of Sirtex liver cancer treatment tech. There is not much competitor on its product either. Only one other company Nordion, is developing similar drug.
At $3 marks, SRX looks cheap. I'm sure Cephalon is watching and may put another offer on the table.
Comments welcome.
I hold lots.
bargain bargain
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.018(13.2%) |
Mkt cap ! $63.66M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 15.0¢ | $440.0K | 2.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 2796049 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 3157161 | 11 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |